Published in Science on February 14, 2003
The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 13.87
The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J Clin Invest (2005) 2.91
Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut (2005) 2.37
Unifying roles for regulatory T cells and inflammation in cancer. Int J Cancer (2010) 1.98
SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J Clin Invest (2006) 1.92
Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci U S A (2007) 1.82
Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A (2009) 1.81
Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J Virol (2008) 1.63
Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One (2013) 1.40
Cancer inflammation and regulatory T cells. Int J Cancer (2010) 1.40
TGF-beta and 'adaptive' Foxp3(+) regulatory T cells. J Mol Cell Biol (2009) 1.34
The control of CD4+CD25+Foxp3+ regulatory T cell survival. Biol Direct (2008) 1.28
Microbial reprogramming inhibits Western diet-associated obesity. PLoS One (2013) 1.21
Roles for inflammation and regulatory T cells in colon cancer. Toxicol Pathol (2009) 1.18
Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology (2007) 1.16
Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma. Immunology (2006) 1.14
Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells. Retrovirology (2007) 1.10
Mutations in bone marrow-derived stromal stem cells unmask latent malignancy. Stem Cells Dev (2010) 1.05
The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review. Int J Inflam (2010) 0.99
T cell directives for transcriptional regulation in asthma. Springer Semin Immunopathol (2003) 0.98
Regulation of granulomatous inflammation in experimental models of schistosomiasis. Infect Immun (2004) 0.92
Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. Proc Natl Acad Sci U S A (2005) 0.90
PARP-1 controls immunosuppressive function of regulatory T cells by destabilizing Foxp3. PLoS One (2013) 0.90
Factor VIII-pulsed dendritic cells reduce anti-factor VIII antibody formation in the hemophilia A mouse model. Exp Hematol (2009) 0.90
Lack of endogenous IL-10 enhances production of proinflammatory cytokines and leads to Brucella abortus clearance in mice. PLoS One (2013) 0.90
Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLoS One (2014) 0.89
Dietary microbes modulate transgenerational cancer risk. Cancer Res (2015) 0.88
Mechanisms Underlying CD4+ Treg Immune Regulation in the Adult: From Experiments to Models. Front Immunol (2013) 0.86
Within-woman change in regulatory T cells from pregnancy to the postpartum period. J Reprod Immunol (2010) 0.86
A population dynamics analysis of the interaction between adaptive regulatory T cells and antigen presenting cells. PLoS One (2008) 0.85
Adrenergic β2 receptor activation stimulates anti-inflammatory properties of dendritic cells in vitro. PLoS One (2014) 0.82
Probiotic 'glow of health': it's more than skin deep. Benef Microbes (2014) 0.80
A stochastic chemical dynamic approach to correlate autoimmunity and optimal vitamin-D range. PLoS One (2014) 0.80
'Hygienic' lymphocytes convey increased cancer risk. J Anal Oncol (2014) 0.79
The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation. Chimerism (2011) 0.79
Cinnamon extract suppresses experimental colitis through modulation of antigen-presenting cells. World J Gastroenterol (2011) 0.78
Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model. Cell Mol Immunol (2012) 0.77
Helicobacter hepaticus, a new pathogenic species of the Helicobacter genus: Similarities and differences with H. pylori. Iran J Microbiol (2013) 0.76
Regulatory T cells in colorectal cancer: from biology to prognostic relevance. Cancers (Basel) (2011) 0.75
Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science (2003) 14.04
Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med (2006) 7.76
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature (2010) 6.44
IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med (2006) 5.76
Regulatory T cells and intestinal homeostasis. Immunol Rev (2005) 3.82
Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity (2010) 3.51
Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity (2008) 3.40
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med (2012) 2.11
The interleukin-23 axis in intestinal inflammation. Immunol Rev (2008) 2.06
Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease. Gastroenterology (2010) 2.01
TLR2-independent induction and regulation of chronic intestinal inflammation. Eur J Immunol (2010) 1.55
Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat Immunol (2005) 1.30
Control of intestinal homeostasis by regulatory T cells and dendritic cells. Semin Immunol (2007) 1.27
Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation. J Exp Med (2012) 1.10
Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cell-mediated colitis. J Immunol (2013) 1.06
Innate immune activation in intestinal homeostasis. J Innate Immun (2011) 0.94
Control of intestinal inflammation by interleukin-10. Curr Top Microbiol Immunol (2014) 0.92
Experimental mouse models of T cell-dependent inflammatory bowel disease. Methods Mol Biol (2014) 0.84
Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med (2017) 0.75